Companies /Healthcare

Quest Diagnostics Inc

NYSE: DGX Diagnostics & Research
$227.10
▼ $1.29 (−0.56%) today
Markets closed · 5:01pm ET

24/7 Wall St. View

DGX at a Glance

Valuation
Market cap
$25.2B
P/E ratio
24.3
Dividend yield
1.43%
Profitability
Revenue (TTM)
$11.6B
Profit margin
9.2%
EPS (TTM)
$9.42
Price
52-week range
$168 – $248
24/7 target
$274.15
Street target
$247.73
Earnings
Next report
Oct 22, 2026

Headquartered in Secaucus, NJ Fiscal year ends December NYSE: DGX questdiagnostics.com

About Quest Diagnostics

Quest Diagnostics Incorporated is a provider of diagnostic information services in the United States, serving approximately half of the nation's physicians and hospitals and one in three adult Americans annually. The company offers a broad range of clinical laboratory testing services, including routine testing, gene-based and esoteric testing, advanced diagnostics such as Alzheimer's disease blood tests (Quest AD-Detect), cancer minimal residual disease testing (Haystack MRD), and cardiometabolic and endocrine testing. Quest operates through physician, hospital, and direct-to-consumer channels, including its questhealth.com platform and partnerships with wearable and wellness companies. With nearly 60,000 employees, the company provides testing insights across healthcare to support disease identification, treatment decisions, and health management. Quest also partners with health systems through its Co-Lab Solutions model, operating joint venture laboratories, and collaborates with companies like Fresenius Medical Care for specialized care areas such as kidney health. Updated

Latest Activity

  • PFEPfizer, Inc. Common Stock (PFE)Sell$15K – $50KMar 10
  • DGXQuest Diagnostics Incorporated Common Stock (DGX)Sell$15K – $50KMar 10
  • TGTTarget Corporation Common Stock (TGT)Sell$15K – $50KMar 10
  • USBU.S. Bancorp Common Stock (USB)Sell$15K – $50KMar 10
Made public 521 days after the earliest trade

Investors are only learning now, 521 days late, that a Ways and Means Republican's household cleared out four positions on the same March 2025 day, including two healthcare names her committee legislates on. The filing lag is the story: disclosure rules give 45 days, and this one took more than a year past that.

DGX Coverage

Frequently Asked Questions

What does Quest Diagnostics do?

Quest Diagnostics Incorporated is a provider of diagnostic information services in the United States, serving approximately half of the nation's physicians and hospitals and one in three adult Americans annually.

What is the DGX stock price target?

24/7 Wall St.'s 12-month price target for DGX is $274.15, rated Buy. The Wall Street consensus target is $247.73. DGX price prediction →